Complete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
- 5 November 1998
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 339 (19) , 1341-1348
- https://doi.org/10.1056/nejm199811053391901
Abstract
Two reports from China have suggested that arsenic trioxide can induce complete remissions in patients with acute promyelocytic leukemia (APL). We evaluated this drug in patients with APL in an attempt to elucidate its mechanism of action.Keywords
This publication has 37 references indexed in Scilit:
- The caspase family of cysteine proteasesBritish Medical Bulletin, 1997
- Efflux-Mediated Resistance to Arsenicals in Arsenic-Resistant and -Hypersensitive Chinese Hamster CellsToxicology and Applied Pharmacology, 1996
- A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoproteinCell, 1994
- The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzymeCell, 1993
- Arsenical-resistant trypanosomes lack an unusual adenosine transporterNature, 1993
- Pharmacokinetic Properties of the Trypanocidal Drug MelarsoprolChemotherapy, 1993
- Molecular evaluation of residual disease as a predictor of relapse in acute promyelocytic leukaemiaThe Lancet, 1992
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Molecular Analysis of Acute Promyelocytic Leukemia Breakpoint Cluster Region on Chromosome 17Science, 1990